EQ - Equillium Inc
Previous close
1.08
0 0%
Share volume: 119,885
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.08
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-15 | 2022-11-14 | 2023-03-23 | 2023-05-11 | 2023-08-09 | 2023-11-08 | 2024-03-25 | 2024-05-09 | |
| Total revenue | 0.000 | 0.000 | 15.759 M | 8.879 M | 9.124 M | 8.870 M | 9.211 M | 10.689 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 15.759 M | 8.879 M | 9.124 M | 8.870 M | 9.211 M | 10.689 M | |
| nan% | inf% | -43.66% | 2.76% | -2.78% | 3.84% | 16.05% | |||
| Operating expenses | 13.552 M | 13.237 M | 13.717 M | 12.987 M | 12.715 M | 12.493 M | 12.411 M | 13.480 M | |
| Selling general and admin | 4.064 M | 4.466 M | 5.192 M | 3.715 M | 3.105 M | 3.519 M | 3.228 M | 3.737 M | |
| Research and development | 9.488 M | 8.771 M | 8.525 M | 9.272 M | 9.610 M | 8.974 M | 9.183 M | 9.743 M | |
| Total expenses | 13.552 M | 13.237 M | 13.717 M | 12.987 M | 12.715 M | 12.493 M | 12.411 M | 13.480 M | |
| -2.32% | 3.63% | -5.32% | -2.09% | -1.75% | -0.66% | 8.61% | |||
| Operating income | -13.552 M | -13.237 M | 2.042 M | -4.108 M | -3.591 M | -3.623 M | -3.200 M | -2.791 M | |
| Ebit | -13.552 M | -13.237 M | 2.042 M | -4.108 M | -3.591 M | -3.623 M | -3.200 M | -2.791 M | |
| Pretax income | -14.129 M | -13.655 M | 2.773 M | -3.880 M | -3.335 M | -3.214 M | -2.326 M | -2.734 M | |
| -3.35% | -120.31% | -239.92% | -14.05% | -3.63% | -27.63% | 17.54% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 60.000 K | 8.000 K | 496.000 K | 16.000 K | 0.000 | |
| Net income basic | -14.129 M | -13.655 M | 2.773 M | -3.940 M | -3.343 M | -3.710 M | -2.342 M | -2.734 M | |
| 3.35% | 120.31% | -242.08% | 15.15% | -10.98% | 36.87% | -16.74% | |||
| Net income | -14.129 M | -13.655 M | 2.773 M | -3.940 M | -3.343 M | -3.710 M | -2.342 M | -2.734 M | |
| 3.35% | 120.31% | -242.08% | 15.15% | -10.98% | 36.87% | -16.74% |